Tuberculosis transmission and infection control in congregate settings

Reichman and Hershfield's Tuberculosis: A Comprehensive, International Approach, Third Edition

Volumn , Issue , 2006, Pages 793-821

  Nardell, Edward A ^a   Fennelly, Kevin P ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876135924     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (86)

1. Moll A, Gandhi NR, Pawinski R, et al. Presented at: 13th Conference on Retroviruses and Opportunistic Infections [abstr]. Denver, CO, 2006; 5-8.
2. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348:119-128.
3. Bonifacio N, Saito M, Gilman RH, et al. High risk for tuberculosis in hospital physicians, Peru. Emerg Infect Dis 2002; 8:747-748.
4. Silva VM, Cunha AJ, Oliveira JR, et al. Medical students at risk of nosocomial transmission of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2000; 4:420-426.
5. Harries AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FM. Preventing tuberculosis among health workers in Malawi. Bull World Health Organ 2002; 80:526-531.
6. Kruuner A, Danilovitsh M, Pehme L, Laisaar T, Hoffner SE, Katila ML. Tuberculosis as an occupational hazard for health care workers in Estonia. Int J Tuberc Lung Dis 2001; 5:170-176.
7. Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996; 276: 1229-1235.
8. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City—turning the tide. N Engl J Med 1995; 333:229-233.
9. Ritacco V, Di Lonardo M, Reniero A, et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 1997; 176:637-642.
10. Barnes PF, Yang Z, Pogoda JM, et al. Foci of tuberculosis transmission in central Los Angeles. Am J Respir Crit Care Med 1999; 159:1081-1086.
11. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330:1710-1716.
12. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330:1703-1709.
13. Cohen T, Murray M. Incident tuberculosis among recent US immigrants and exogenous reinfection. Emerg Infect Dis 2005; 11:725-728.
14. Verver S, Warren RM, Munch Z, et al. Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet 2004; 363:212-214.
15. Nardell EA. Environmental control of tuberculosis. Sem Respir Infect 2003; 18: 307-319.
16. Shin SS, Pashechnikov AD, Gelmanova IY, et al. Treatment outcomes in an integrated civilian and prison multi-drug resistant tuberculosis treatment program in Russia. Inter J Tuberc Lung Dis 2006; 10(4): 402-408.
17. Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer P. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med 2004; 59:1529-1539.
18. Wells W. On air-borne infection: II Droplets and droplet nuclei. Am J Hyg 1934; 20:611-618.
19. Riley RL, Mills CC, O’Grady F, Sultan LU, Wittstadt F, Shivpuri DN. Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. Am Rev Respir Dis 1962; 85:511-525.
20. Riley R, Wells W, Mills C, Nyka W, McLean R. Air hygiene in tuberclosis: quantitative studies of infectivity and control in a pilot ward. Am Rev Tuberc Pulmon Dis 1959; 75:420-431.
21. Wells W, Ratcliff H, Crumb C. On the mechanism of droplet nuclei infection II: quantitative experimental airborne infection in rabbits. Am J Hyg 1948; 47:11.
22. Kundsin RB. Airborne Contagion. New York: The New York Academy of Sciences, 1980.
23. Sultan L, Nyka C, Mills C, O’Grady F, Riley R. Tuberculosis disseminators—a study of variability of aerial infectivity of tuberculosis patients. Am Rev Respir Dis 1960; 82:358-369.
24. van Geuns HA, Meijer J, Styblo K. Results of contact examination in Rotterdam, 1967-1969. Bull Int Union Tuberc 1975; 50:107-121.
25. Borgdorff MW, Nagelkerke NJ, de Haas PE, van Soolingen D. Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases. Am J Epidemiol 2001; 154:934-943.
26. Curtis AB, Ridzon R, Vogel R, et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med 1999; 341:1491-1495.
27. Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis 1969; 99:109-111.
28. Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353:444-449.
29. Catanzaro A. Nosocomial tuberculosis. Am Rev Respir Dis 1982; 125:559-562.
30. Leonard MK, Osterholt D, Kourbatova EV, Del Rio C, Wang W, Blumberg HM. How many sputum specimens are necessary to diagnose pulmonary tuberculosis? Am J Infect Control 2005; 33:58-61.
31. Anderson C, Inhaber N, Menzies D. Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis. Am J Respir Crit Care Med 1995; 152:1570-1574.
32. Templeton GL, Illing LA, Young L, Cave D, Stead WW, Bates JH. The risk for transmission of Mycobacterium tuberculosis at the bedside and during autopsy [see comments]. Ann Intern Med 1995; 122:922-925.
33. Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis 2003; 3:13-21.
34. Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med 2004; 10:1117-1121.
35. Maloney SA, Pearson ML, Gordon MT, Del Castillo R, Boyle JF, Jarvis WR. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med 1995; 122:90-95.
36. Malasky C, Jordan T, Potulski F, Reichman LB. Occupational tuberculous infections among pulmonary physicians in training. Am Rev Respir Dis 1990; 142: 505-507.
37. Fridkin SK, Manangan L, Bolyard E, Jarvis WR. SHEA-CDC TB survey. Part I: status of TB infection control programs at member hospitals, 1989-1992. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1995; 16: 129-134.
38. Fridkin SK, Manangan L, Bolyard E, Jarvis WR. SHEA-CDC TB survey. Part II: efficacy of TB infection control programs at member hospitals, 1992. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1995; 16: 135-140.
39. Hutton MD, Stead WW, Cauthen GM, Bloch AB, Ewing WM. Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis 1990; 161: 286-295.
40. Nardell EA, Keegan J, Cheney SA, Etkind SC. Airborne infection. Theoretical limits of protection achievable by building ventilation. Am Rev Respir Dis 1991; 144: 302-306.
41. Ko G, First MW, Burge HA. Influence of relative humidity on particle size and UV sensitivity of Serratia marcescens and Mycobacterium bovis BCG aerosols. Tuber Lung Dis 2000; 80:217-228.
42. Stead WW. Variation in vulnerability to tuberculosis in America today: random, or legacies of different ancestral epidemics? Int J Tuberc Lung Dis 2001; 5: 807-814.
43. Kritski AL, Marques MJ, Rabahi MF, et al. Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 1996; 153:331-335.
44. Fine PE. The BCG story: lessons from the past and implications for the future. Rev Infect Dis 1989; 11(suppl 2):S353-S359.
45. Ko G, Burge HA, Nardell EA, Thompson KM. Estimation of tuberculosis risk and incidence under upper room ultraviolet germicidal irradiation in a waiting room in a hypothetical scenario. Risk Anal 2001; 21:657-673.
46. Gammaitoni L, Nucci MC. Using a mathematical model to evaluate the efficacy of TB control measures. Emerg Infect Dis 1997; 3:335-342.
47. CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. Morb Mort Wkly Rep 2005; 54:1-147.
48. Blumberg HM, Watkins DL, Berschling JD, et al. Preventing the nosocomial transmission of tuberculosis. Ann Intern Med 1995; 122:658-663.
49. Scott B, Schmid M, Nettleman MD. Early identification and isolation of inpatients at high risk for tuberculosis. Arch Intern Med 1994; 154:326-330.
50. Wells WF, Wilder TS. The environmental control of epidemic contagion: I. An epdi-demiologic study of radiant disinfection of air in day schools. Am J Hyg 1942; 35: 97-121.
51. McLean R. The effects of ultraviolet radiation upon the transmission of epidemic influenza in long-term hospital patients. Am Rev Resp Dis 1961; 83(suppl):36.
52. Riley RL. Ultraviolet air disinfection: rationale for whole building irradiation. Infect Control Hosp Epidemiol 1994; 15:324-325; discussion 326-328.
53. Menzies D, Fanning A, Yuan L, FitzGerald JM. Hospital ventilation and risk for tuberculous infection in Canadian health care workers. Canadian Collaborative Group in Nosocomial Transmission of TB. Ann Intern Med 2000; 133:779-789.
54. Nardell EA. Interrupting transmission from patients with unsuspected tuberculosis: a unique role for upper-room ultraviolet air disinfection. Am J Infect Control 1995; 23:156-164.
55. Rutala WA, Jones SM, Worthington JM, Reist PC, Weber DJ. Efficacy of portable filtration units in reducing aerosolized particles in the size range of Mycobacterium tuberculosis. Infect Control Hosp Epidemiol 1995; 16:391-398.
56. Loudon RG, Bumgarner LR, Lacy J, Coffman GK. Aerial transmission of mycobacteria. Am Rev Respir Dis 1969; 100:165-171.
57. Houk VN, Baker JH, Sorensen K, Kent DC. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health 1968; 16:26-35.
58. Nardell EA. Fans, filters, or rays? Pros and cons of the current environmental tuberculosis control technologies. Infect Control Hosp Epidemiol 1993; 14:681-685.
59. First MW, Weker RA, Yasui S, Nardell EA. Monitoring human exposures to upper-room germicidal ultraviolet irradiation. J Occup Environ Hyg 2005; 2:285-292.
60. Brickner PW, Vincent RL, First M, Nardell E, Murray M, Kaufman W. The application of ultraviolet germicidal irradiation to control transmission of airborne disease: bioterrorism countermeasure. Public Health Rep 2003; 118:99-114.
61. Riley RL, Nardell EA. Clearing the air. The theory and application of ultraviolet air disinfection. Am Rev Respir Dis 1989; 139:1286-1294.
62. Ko G, First MW, Burge HA. The characterization of upper-room ultraviolet germicidal irradiation in inactivating airborne microorganisms. Environ Health Perspect 2002; 110:95-101.
63. Nicas M, Miller SL. A multi-zone model evaluation of the efficacy of upper-room air ultraviolet germicidal irradiation. Appl Occup Environ Hyg 1999; 14:317-328.
64. First M, Nardell E, Chaission W, Riley R. Guidelines for the application of upper-room ultraviolet germicidal irradiation for preventing transmission of airborne contagion—Part II: design and operations guidance. ASHRAE Transact 1999; 105:877-887.
65. First M, Nardell E, Chaission W, Riley R. Guidelines for the application of upper-room ultraviolet germicidal irradiation for preventing transmission of airborne contagion—Part I: Basic principles. ASHRAE Transact 1999; 105:869-876.
66. NIOSH. Criteria for a Recommended Standard for Occupational Exposure to Ultur-aviolet Radiation. Cincinnati, Ohio, U.S.: National Institute for Occupational Safety and Health, HHS, CDC, 1972.
67. Centers for Disease Control. NIOSH Guide to the selection and use of particulate respirators certified under 42 CFR 84. [DHHS (NIOSH) Pub No. 96-101]. Cincinnati, Ohio, U.S.: National Institutes for Occupational Safety and Health, HHS, CDC, 1996.
68. NIOSH. Respiratory protective devices, 42 CFR Part 84. Cincinnatti, Ohio, U.S.: National Institute for Occupational Safety and Health, HHS, CDC, 1995.
69. Coffey CC, Lawrence RB, Campbell DL, Zhuang Z, Calvert CA, Jensen PA. Fitting characteristics of eighteen N95 filtering-facepiece respirators. J Occup Environ Hyg 2004; 1:262-271.
70. Adal KA, Anglim AM, Palumbo CL, Titus MG, Coyner BJ, Farr BM. The use of high-efficiency particulate air-filter respirators to protect hospital workers from tuberculosis. A cost-effectiveness analysis. N Engl J Med 1994; 331:169-173.
71. Nettleman MD, Fredrickson M, Good NL, Hunter SA. Tuberculosis control strategies: the cost of particulate respirators. Ann Intern Med 1994; 121:37-40.
72. Nicas M. Respiratory protection and the risk of Mycobacterium tuberculosis infection. Am J Ind Med 1995; 27:317-333.
73. Fennelly K, Nardell E. The relative efficacy of respirators and room ventilation in preventing occupational tuberculosis. Inf Control Hosp Epidemiol 1998; 19: 754-759.
74. Barnhart S, Sheppard L, Beaudet N, Stover B, Balmes J. Tuberculosis in health care settings and the estimated benefits of engineering controls and respiratory protection. J Occup Environ Med 1997; 39:849-854.
75. Kenyon TA, Ridzon R, Luskin-Hawk R, et al. A nosocomial outbreak of multidrug-resistant tuberculosis. Ann Intern Med 1997; 127:32-36.
76. von Reyn CF, Horsburgh CR, Olivier KN, et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001; 5:1122-1128.
77. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170:59-64.
78. Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR. Recomm Rep 2003; 52(RR-2):15-18.
79. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286:1740-1747.
80. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293:2746-2755.
81. Yanai H, Limpakarnjanarat K, Uthaivoravit W, Mastro TD, Mori T, Tappero JW. Risk of Mycobacterium tuberculosis infection and disease among health care workers, Chiang Rai, Thailand. Int J Tuberc Lung Dis 2003; 7:36-45.
82. WHO. Guidelines for the prevention of tuberculosis in health care facilities in resource-limited settings. Geneva: WHO, 1999.
83. Farmer PE, Bayona J, Becerra MC, et al. Poverty, inequality, and drug resistance: meeting community needs. Proc Int Union Against Tuberc Lung Dis North Am Reg Conf 1997:88-102.
84. Di Perri G, Cadeo GP, Castelli F, et al. Transmission of HIV-associated tuberculosis to healthcare workers. Infect Control Hosp Epidemiol 1993; 14:67-72.
85. Willingham FF, Schmitz TL, Contreras M, et al. Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru. Emerg Infect Dis 2001; 7:123-127.
86. http://www.who.int/docstore/gtb/publications/prisonsNTP/PDF/tbprisonsntp.pdf.